The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 27, 2021

Filed:

Sep. 12, 2019
Applicant:

Biosense Webster (Israel) Ltd., Yokneam, IL;

Inventors:

Xiangming Zhang, Irvine, CA (US);

Nader Ghaly, Irvine, CA (US);

Eid Adawi, Tur'an, IL;

Moe Habib Bishara, Irvine, CA (US);

Kendra Anita McInnis, Irvine, CA (US);

Assaf Govari, Haifa, IL;

Christopher Thomas Beeckler, Brea, CA (US);

Joseph Thomas Keyes, Sierra Madre, CA (US);

Rowan Olund Hettel, Irvine, CA (US);

Kevin Justin Herrera, West Covina, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/00 (2006.01); A61B 18/12 (2006.01); A61B 18/14 (2006.01); A61M 25/10 (2013.01);
U.S. Cl.
CPC ...
A61B 18/1492 (2013.01); A61B 18/1206 (2013.01); A61M 25/10 (2013.01); A61B 2018/00351 (2013.01); A61B 2018/00375 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00755 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/1417 (2013.01); A61M 2025/1079 (2013.01);
Abstract

The subject of this disclosure includes systems, devices and methods to treat a predetermined patient population for paroxysmal atrial fibrillation, the method including ablating tissue of one or more targeted pulmonary veins with one or more of a plurality of the electrodes of an independently controlled multi-electrode radiofrequency balloon catheter, the balloon catheter comprising the plurality of electrodes for radiofrequency ablation that are independently controllable; determining a predictor, based on ablation parameters of the balloon catheter, of single shot pulmonary vein isolation (PVI) success rate; and achieving, based on the predictor and step of ablating tissue, a single shot isolation PVI success rate in the isolation of all targeted pulmonary veins for the predetermined patient population.


Find Patent Forward Citations

Loading…